ONWARD – MedTech Developments for Spinal Cord Injury

Dave Marver, CEO of ONWARD, discusses the work they are doing with both non-invasive and implantable neuromodulation technologies to improve the quality of life for people with spinal cord injury. The company just enrolled the first patient in its clinical trial, Up-LIFT, which is testing the safety and effectiveness of ARC Therapy™ in restoring hand and arm function in people living with spinal cord injury.

Dave Marver became the CEO of ONWARD in July of 2020. He has a substantial track record in the medical technology industry, driving success as a senior executive across a range of companies in the United States and Europe. He spent nearly 15 years in a variety of executive positions at Medtronic, a global leader in medical technology. He was also CEO of Cardiac Science Corporation, then a NASDAQ-listed manufacturer of automated external defibrillators, stress test treadmills, and electrocardiograph machines. Dave also co-founded two startup companies, one in orthopedics and another in sports technology which developed two TIME Magazine Inventions of the Year. Mr. Marver holds a BA from Duke University and an MBA from the Anderson School of Management at the University of California Los Angeles.